Junya Kanda1, Takakazu Kawase2, Hidenori Tanaka3, Hiroto Kojima3, Naoyuki Uchida4, Koji Nagafuji5, Yoshiko Matsuhashi6, Yuju Ohno7, Makoto Onizuka8, Junji Tanaka9, Tatsuo Ichinohe2, Yoshiko Atsuta10 (1.Department of Hematology, Kyoto University Hospital, Kyoto, Japan, 2.Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan, 3.HLA Foundation Laboratory, Kyoto, Japan, 4.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 5.Division of Hematology and Oncology, Kurume University Hospital, Kurume, Japan, 6.Department of Hematology, Kawasaki Medical School Hospital, Kurashiki, Japan, 7.Department of Internal Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan, 8.Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan, 9.Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan, 10.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan)
Session information
Oral Session
Oral Session 3-8A Cord Blood Transplanation
Sun. Oct 13, 2019 9:00 AM - 10:00 AM No.8 (Tokyo International Forum, 1F Hall D1)
Chair: Naoyuki Uchida (Department of Hematology, Toranomon Hospital)
Masamitsu Yanada1, Takaaki Konuma2, Yachiyo Kuwatsuka3, Tadakazu Kondo4, Takahito Kawata4,5, Satoshi Takahashi2, Naoyuki Uchida6, Shigesaburo Miyakoshi7, Masatsugu Tanaka8, Yukiyasu Ozawa9, Masashi Sawa10, Hirohisa Nakamae11, Nobuyuki Aotsuka12, Junya Kanda4, Minoko Takanashi13, Yoshinobu Kanda14, Yoshiko Atsuta15,16, Shingo Yano17 (1.Aichi Cancer Center, Nagoya, 2.The Institute of Medical Science, The University of Tokyo, Tokyo, 3.Nagoya University Hospital, Nagoya, 4.Graduate School of Medicine, Kyoto University, Kyoto, 5.Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, 6.Toranomon Hospital, Tokyo, 7.Tokyo Metropolitan Geriatric Hospital, Tokyo, 8.Kanagawa Cancer Center, Yokohama, 9.Japanese Red Cross Nagoya First Hospital, Nagoya, 10.Anjo Kosei Hospital, Anjo, 11.Graduate School of Medicine, Osaka City University, Osaka, 12.Japanese Red Cross Narita Hospital, Narita, 13.Japanese Red Cross Society, Tokyo, 14.Jichi Medical University, Shimotsuke, 15.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, 16.Nagoya University Graduate School of Medicine, Nagoya, 17.The Jikei University School of Medicine, Tokyo)
Taiki Ando1, Yasufumi Ishiyama1, Takayoshi Tachibana1, Masatsugu Tanaka1, Heiwa Kanamori1, Hideaki Nakajima2 (1.Depertment of Hematology, Kanagawa Cancer Center, Kanagawa, Japan, 2.Depertment of Hematology and Immunology, Yokohama City University Hospital, Japan)
Nobuyuki Takayama, Makoto Kobayashi, Ayako Kuwabara, Masashi Seki, Emi Yoshimori, Emi Momose, Norihide Satoh (Department of Hematology, Kyorin University, Tokyo, Japan)
Takaaki Konuma1, Maki Oiwa1, Mai Mizusawa1, Masamichi Isobe1, Seiko Kato1, Tokiko Nagamura2, Satoshi Takahashi1, Arinobu Tojo1 (1.Hematol., IMSUT, Tokyo, Japan, 2.Transfusion, IMSUT, Tokyo, Japan)
Koji Jimbo1, Takaaki Konuma1, Motoko Mizukami2, Etsuko Nagai2, Maki Oiwa1, Masamichi Isobe1, Seiko Kato1, Satoshi Takahashi1, Arinobu Tojo1 (1.Department of Hematology/Oncology, Institute of Medical Science, University of Tokyo, 2.Department of Laboratory Medicine, Institute of Medical Science, University of Tokyo)